Spotlight on Psoriasis
Showcasing the latest news and clinical breakthroughs in care, Spotlight on Psoriasis shines an educational beacon for healthcare professionals dedicated to improving patients’ quality of life and outcomes.
Here you’ll find leading dermatology specialists and other allied healthcare professionals sharing research updates and novel insights on collaborative, evidence-based practices to achieve skin clearance and optimize the treatment of patients with psoriasis.
16-30 of 51
IL-17A Inhibition and the Stress Response in Psoriasis
AudioAbstractsIL-17A Inhibition and the Stress Response in Psoriasis
Ryan Quigley
Addressing Diagnostic Gaps in Psoriasis for Skin of Color
DermConsultAddressing Diagnostic Gaps in Psoriasis for Skin of Color
Megan R Hauptman, MD
Key Factors That Influence Psoriasis Diagnosis and Management
DermConsultKey Factors That Influence Psoriasis Diagnosis and Management
Christopher Bunick, MD, PhD, FAAD
Exploring the Future of Psoriasis Treatment with Oral Agents
DermConsultExploring the Future of Psoriasis Treatment with Oral Agents
Christopher Bunick, MD, PhD, FAAD
Rethinking the Routine: Moving from Topicals to Systemics in Psoriasis
DermConsultRethinking the Routine: Moving from Topicals to Systemics in Psoriasis
Christopher Bunick, MD, PhD, FAAD
Rethinking Hepatotoxicity Risk in Oral Psoriasis Therapies
AudioAbstractsRethinking Hepatotoxicity Risk in Oral Psoriasis Therapies
Ryan Quigley
- advertisement
Targeting Psoriasis at the Source: New Evidence for Interferon Receptor Therapies
DermConsultTargeting Psoriasis at the Source: New Evidence for Interferon Receptor Therapies
Assessing the Role of Metabolic Factors in Psoriasis Management
AudioAbstractsAssessing the Role of Metabolic Factors in Psoriasis Management
Ryan Quigley
Recognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
DermConsultRecognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
Unmasking Psoriasis in Skin of Color: Clinical Clues and Care Strategies
DermConsultUnmasking Psoriasis in Skin of Color: Clinical Clues and Care Strategies
Amy McMichael, MD
Understanding Sebopsoriasis: Navigating the Clinical Overlap of Dermatoses
DermConsultUnderstanding Sebopsoriasis: Navigating the Clinical Overlap of Dermatoses
Raj Chovatiya, MD, PhD, MSCI, FAAD
Guselkumab in Skin of Color: Results from a Randomized Phase 3b Psoriasis Trial
DermConsultGuselkumab in Skin of Color: Results from a Randomized Phase 3b Psoriasis Trial
- advertisement
Real-World Data Highlights Class-Based Differences in Psoriasis Biologic Outcomes
DermConsultReal-World Data Highlights Class-Based Differences in Psoriasis Biologic Outcomes
Roflumilast Foam for Psoriasis: Efficacy, Tolerability, and Clinical Relevance
DermConsultRoflumilast Foam for Psoriasis: Efficacy, Tolerability, and Clinical Relevance
Exploring the Connection Between E-Cigarette Use and Psoriasis
Clinician's RoundtableExploring the Connection Between E-Cigarette Use and Psoriasis
Joe K. Tung, MD, MBA